J Korean Neurosurg Soc.  1999 Feb;28(2):228-236.

Comparison between Acetazolamide and Dipyridamole Activated SPECT for Cerebral Vascular Reserve Capacity Measurement

Affiliations
  • 1Department of Neurosurgery and Nuclear Medicine, Gospel Hospital, Kosin University Medical College, Pusan, Korea.

Abstract

Object of this study was to make comparison between acetazolamide and dipyridamole activated SPECT for measurement of cerebral vascular reserve capacity. This study was also carried out to evaluate response in acetazolamide and dipyridamole activated SPECT in relation to clinical parameters, such as Glasgow Coma Scale, Hunt & Hess grade, Fisher grade and Glasgow Outcome Scale. It is concluded from study that. Acetazolamide and dipyridamole activated SPECT study proved to be valuable for cerebral vascular reserve capacity. Dipyridamole activated SPECT study was somewhat equivocal because of systemic vascular dilatation effect, but this problem could be resolved by Gamma Count Ratio. Although there were minimal transient side effect of dipyridamole such as dizziness, no complication.

Keyword

Dipyridamole SPECT; Acetazolamide SPECT; Cerebral vascular reserve capacity; Subarachnoid hemorrhage

MeSH Terms

Acetazolamide*
Dilatation
Dipyridamole*
Dizziness
Glasgow Coma Scale
Glasgow Outcome Scale
Subarachnoid Hemorrhage
Tomography, Emission-Computed, Single-Photon*
Acetazolamide
Dipyridamole
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr